Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC

scientific article published on May 2012

Comorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/YCO.0B013E3283523DCC
P932PMC publication ID3767413
P698PubMed publication ID22449770

P50authorDeborah S HasinQ88070100
P2093author name stringBari Kilcoyne
P2860cites workCo-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ44832144
The co-occurrence of DSM-IV alcohol abuse in DSM-IV alcohol dependence: results of the National Epidemiologic Survey on Alcohol and Related Conditions on heterogeneity that differ by population subgroupQ45047369
The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristicsQ45230125
Co-occurring DSM-IV drug abuse in DSM-IV drug dependence: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ46698624
Longitudinal predictors of first time depression treatment utilization among adults with depressive disordersQ48766307
Three-year incidence and predictors of first-onset of DSM-IV mood, anxiety, and substance use disorders in older adults: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related ConditionsQ48896022
Prevalence, correlates, and comorbidity of DSM-IV obsessive-compulsive personality disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Q50772243
Predictors of persistence of social anxiety disorder: a national study.Q50789062
What is the association between traumatic life events and alcohol abuse/dependence in people with and without PTSD? Findings from a nationally representative sample.Q50793718
Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.Q51903857
Personality disorder and impaired functioning from adolescence to adulthood.Q51904154
Alcohol and drug abuse in patients with affective syndromes.Q54793999
Prevalence, Correlates, and Disability of Personality Disorders in the United StatesQ22241105
An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sampleQ24630363
Borderline personality disorder co-morbidity: relationship to the internalizing–externalizing structure of common mental disordersQ24635048
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) StudyQ28259349
Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related ConditionsQ34155570
Gender differences in social anxiety disorder: results from the national epidemiologic sample on alcohol and related conditionsQ34214738
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ34338064
Distinguishing general and specific personality disorder features and implications for substance dependence comorbidityQ34559452
Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related ConditionsQ34645025
Personality disorders and cigarette smoking among adults in the United StatesQ34984602
Disordered (pathologic or problem) gambling and axis I psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Q35116616
Alcohol involvement as a function of co-occurring alcohol use disorders and major depressive episode: evidence from the National Epidemiologic Survey on Alcohol and Related ConditionsQ35134404
Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders studyQ35171828
Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. populationQ35231680
Relationship of personality disorders to the course of major depressive disorder in a nationally representative sampleQ35460466
Temporal relationships between overweight and obesity and DSM-IV substance use, mood, and anxiety disorders: results from a prospective study, the National Epidemiologic Survey on Alcohol and Related ConditionsQ35583164
Alcohol dependence is related to overall internalizing psychopathology load rather than to particular internalizing disorders: evidence from a national sampleQ35605874
Psychiatric comorbidity and the persistence of drug use disorders in the United StatesQ35678302
Childhood maltreatment and the structure of common psychiatric disordersQ35719059
Influence of comorbid mental disorders on time to seeking treatment for major depressive disorderQ35778650
Predictors of persistent nicotine dependence among adults in the United StatesQ35915739
The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Q36058152
Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).Q36330029
Personality disorders and the 3-year course of alcohol, drug, and nicotine use disordersQ36407347
Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related ConditionsQ36441841
Gambling problem severity and psychiatric disorders among Hispanic and white adults: findings from a nationally representative sampleQ36837121
Alcohol-use disorder severity predicts first-incidence of depressive disordersQ37156999
Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related ConditionsQ37397699
Panic attacks as a risk for later psychopathology: results from a nationally representative survey.Q39772372
The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sampleQ40981146
A longitudinal study of risk factors for incident drug use in adults: findings from a representative sample of the US populationQ43813430
Non-medical prescription use increases the risk for the onset and recurrence of psychopathology: results from the National Epidemiological Survey on Alcohol and Related Conditions.Q43904586
The structure of common mental disordersQ44243916
Drug and alcohol abuse among psychiatric admissions. A multidrug clinical-tosicologic studyQ44362894
Pathological gambling and the structure of common mental disordersQ44459414
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectUnited States of AmericaQ30
substance PQ411041
comorbidityQ1414874
P304page(s)165-171
P577publication date2012-05-01
P1433published inCurrent Opinion in PsychiatryQ15749265
P1476titleComorbidity of psychiatric and substance use disorders in the United States: current issues and findings from the NESARC
P478volume25

Reverse relations

cites work (P2860)
Q40582450A cannabinoid receptor 1 polymorphism is protective against major depressive disorder in methadone-maintained outpatients
Q37678716ADHD and the externalizing spectrum: direct comparison of categorical, continuous, and hybrid models of liability in a nationally representative sample
Q36328453Age-varying associations between substance use behaviors and depressive symptoms during adolescence and young adulthood
Q37693443Alcohol stigma and persistence of alcohol and other psychiatric disorders: a modified labeling theory approach
Q37172408Associations between Polygenic Risk for Psychiatric Disorders and Substance Involvement
Q52651111Becoming an Evidence-Based Practitioner.
Q33835356Biological substrates of addiction.
Q37268979Conduct disorder and initiation of substance use: a prospective longitudinal study
Q37325441Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial
Q37692048Cultural Influences on Substance Use Among Hispanic Adolescents and Young Adults: Findings From Project RED.
Q35037069Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems
Q30435189Diagnostic challenges in alcohol use disorder and alcoholic liver disease
Q47607854Effects of the Personalized Recovery Oriented Services (PROS) Program on Hospitalizations
Q34484841Engagement in assertive community treatment as experienced by recovering clients with severe mental illness and concurrent substance use
Q36083857Factors associated with high use of general practitioner and psychiatrist services among patients attending an addiction rehabilitation center
Q36904056Impact of Exposure to Childhood Maltreatment on Transitions to Alcohol Dependence in Women and Men.
Q50180836Individuals developing schizophrenia are hidden among adolescent substance misusers
Q47709682Inhalant Use and Mental Health Problems in Russian Juvenile Delinquents
Q38846312Integrated Dual Disorder Treatment Implementation in a Large State Sample
Q39740604Medication-assisted treatment for substance use disorders within a national community health center research network
Q50344789Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
Q34498313Personality disorders and the persistence of substance use disorders: A reanalysis of published NESARC findings
Q37076690Polysubstance use in cannabis users referred for treatment: drug use profiles, psychiatric comorbidity and cannabis-related beliefs
Q30580766Psychiatric comorbidity and perceived alcohol stigma in a nationally representative sample of individuals with DSM-5 alcohol use disorder
Q38778760Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment
Q40087826Social, familial and psychological risk factors for mood and anxiety disorders in childhood and early adulthood: a birth cohort study using the Danish Registry System
Q39029911Stereotype threat and social function in opioid substitution therapy patients.
Q38607036Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk?
Q33819208Substance-abusing mothers and fathers' willingness to allow their children to receive mental health treatment.
Q92065828Testing Cold and Hot Cognitive Control as Moderators of a Network of Comorbid Psychopathology Symptoms in Adolescence
Q42316088The Challenge Behind the Facade: Substance Abuse and Comorbidities
Q47287924The cross-national structure of mental disorders: results from the World Mental Health Surveys
Q34404372The p Factor: One General Psychopathology Factor in the Structure of Psychiatric Disorders?
Q47652202The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain.
Q58256697Therapeutic Change in a Christian SUD Program: Mental Health, Attachment, and Attachment to God
Q39002018Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs
Q39234941Transdiagnostic Extension of Delusions: Schizophrenia and Beyond

Search more.